ArticleScientific reports2020

MicroRNA-144 represses gliomas progression and elevates susceptibility to Temozolomide by targeting CAV2 and FGF7.

Zhi-Qin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.